|
WO2021069553A1
|
|
Use of liver progenitor or stem cells, lysates thereof, and/or conditioned medium in disorders characterized by vascular hyperpermeability
|
|
WO2020221842A1
|
|
Preparation of human allogeneic liver-derived progenitor cells
|
|
WO2020221843A1
|
|
Preparation of human allogeneic liver-derived progenitor cells
|
|
WO2020193714A1
|
|
Adult liver progenitor cells for treating acute-on-chronic liver failure
|
|
TW202100171A
|
|
Adult liver progenitor cells for treating non-alcoholic fatty liver disease
|
|
WO2020120666A1
|
|
Liver progenitor cells expressing hla-g, and method for obtaining these cells compositions comprising said cells and their use
|
|
TW202043463A
|
|
Cell composition comprising liver progenitor cells expressing hla-e
|
|
AU2015308341A1
|
|
Method for producing adult liver progenitor cells
|
|
EA034878B1
|
|
Method for producing adult liver progenitor cells
|
